GOV.UK
Looking for a New Challenge in 2018?
Whilst we progress our latest recruitment campaign for GMDP Inspectors, Ian Holloway reflects on 30 years of working for the Medicines Regulator.
GDP Inspection Deficiency Data for 2016
To assist wholesalers to understand areas where significant GDP failures have been observed, the GDP Inspectorate has published the inspection deficiency data for 2016.
MHRA GPvP Inspection Metrics for April 2016 to March 2017
The MHRA GPvP inspectorate recently published their latest inspection metrics for the period of April 2016 to March 2017.
Risk Adaption in Clinical Trials of Investigational Medicinal Products (CTIMPs)
MHRA are actively promoting a risk proportionate approach to CTIMPs
GPvP 2018 Symposium - Pre -Symposium Questionnaire
Help us with the key topics you would like to hear about
2018 MHRA Laboratories Symposium
The Inspectorate laboratories group conducts a diverse number of inspections both internationally and across the United Kingdom.
EU-FDA mutual recognition of inspections of medicines manufacturers enters operational phase
Today marks the start of the operational phase of the EU-FDA mutual recognition agreement
International regulators inspecting in the UK
The MHRA has seen an increasing number of inspections being conducted in both the UK and the rest of the EU by regulators from other countries.
PIC/S - Press release and news of TFDA hosted meetings and seminar, September 2017
From 11 to 15 September 2017 I attended the PIC/S Committee meeting, Executive Bureau meeting, and Annual Seminar hosted by the Taiwan Food and Drug Administration (TFDA)
Potential supply issues
The last couple of months have seen some catastrophic weather conditions across the globe. These can have a significant impact upon the pharmaceutical supply chain.